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Abstract
Background: Plasmid mediated antimicrobial resistance in the Enterobacteriaceae is a global problem. The rise of CTX-M
class extended spectrum beta lactamases (ESBLs) has been well documented in industrialized countries. Vietnam is
representative of a typical transitional middle income country where the spectrum of infectious diseases combined with the
spread of drug resistance is shifting and bringing new healthcare challenges.
Methodology: We collected hospital admission data from the pediatric population attending the hospital for tropical
diseases in Ho Chi Minh City with Shigella infections. Organisms were cultured from all enrolled patients and subjected to
antimicrobial susceptibility testing. Those that were ESBL positive were subjected to further investigation. These
investigations included PCR amplification for common ESBL genes, plasmid investigation, conjugation, microarray
hybridization and DNA sequencing of a blaCTX–M encoding plasmid.
Principal Findings:We show that two different blaCTX-M genes are circulating in this bacterial population in this location.
Sequence of one of the ESBL plasmids shows that rather than the gene being integrated into a preexisting MDR
plasmid, the blaCTX-M gene is located on relatively simple conjugative plasmid. The sequenced plasmid (pEG356) carried
the blaCTX-M-24 gene on an ISEcp1 element and demonstrated considerable sequence homology with other IncFI
plasmids.
Significance: The rapid dissemination, spread of antimicrobial resistance and changing population of Shigella spp.
concurrent with economic growth are pertinent to many other countries undergoing similar development. Third generation
cephalosporins are commonly used empiric antibiotics in Ho Chi Minh City. We recommend that these agents should not be
considered for therapy of dysentery in this setting.
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Introduction
Enterobacteriaceae that have the capability to express CTX-M (so
named because of their hydrolytic activity against cefotaxime)
family extended spectrum beta lactamases (ESBLs) have emerged
as a major health threat worldwide [1,2]. Most of the research in
this area is conducted in industrialized countries, where organisms,
such as Escherichia coli and Klebsiella spp., mostly from urinary tract
infections are the commonest source [3,4,5]. Relatively little is
known about the distribution of such genes in organisms found
developing or countries undergoing an economic transition, where
the circulating pathogens may differ.
Enterobacteriaceae capable of producing ESBLs have been described
previously in South East Asia [6,7]. Ho Chi Minh City in southern
Vietnam is typical of many cities where patterns of infectious diseases
are changing due to rapid economic growth, better access to health
care and improving infrastructure. We recently showed that 42% of
healthy people carried ESBL producing bacteria as part of their
regular intestinal flora [8]. This previous work suggested that
commensal organisms play a role in the dissemination and
maintenance of such antimicrobial resistance genes in the population.
Furthermore, the uncontrolled use of antimicrobials in the human
population and in livestock rearing may lead to further problems with
drug resistance and even more limited therapeutic options.
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Shigellosis is a gastrointestinal infection caused by members by
Shigella spp. Due to the faecal oral route of transmission of the
Shigellae, children less than five years old and living in developing
countries have the highest incidence [9,10]. In our hospital in Ho
Chi Minh City, shigellosis is the leading cause of paediatric
diarrhoeal admission with bacterial aetiology. The infection is
typically self limiting, although antimicrobial treatment is
necessary for the young and those that are severely ill as it ensures
fewer complications and curtails the duration of the disease [11].
Fluoroquinolones are the drugs of choice to treat Shigella
infections in both adults and children [12]. However, as with many
other members of the Enterobacteriaceae, mutations in the genes
encoding the target proteins for fluoroquinolones are common in
Shigella [13,14]. Our recent findings show that patients with
shigellosis are staying in hospital for longer periods compared with
5 and 10 years ago and the disease severity has concurrently
increased [15]. Interestingly, at the same time there has been a
significant species shift from S. flexneri to S. sonnei isolated from
patients [15]. Patients here are treated with fluoroquinolones,
however, those patients that do not respond to the standard
therapy are treated with third generation cephalosporins (mainly
ceftriaxone). The intravenous third generation cephalosporins are
amongst the most commonly used antimicrobials in hospitals in
Ho Chi Minh City and the oral second and third generation
cephalosporins are also widely available in the community.
Antimicrobial resistance in the Shigellae is common; these organisms
are closely related to E. coli and are readily transformed by exogenous
DNA [16,17,18]. The distribution of antimicrobial resistance is,
however, often different depending on the species. A multi-centre
study across Asia demonstrated that S. flexneri were more likely to be
resistant to ampicillin, whilst S. sonnei were more likely to be resistant
to co-trimoxazole [19]. Resistance patterns and species dominance
are variable depending on the specific location [20,21,22].
We have previously reported the rapid emergence of third
generation cephalosporin resistant Shigella in Vietnam, where we
noted the routine isolation of a number of ESBL producing
microorganisms [15]. Here, we present data suggesting that ESBL
negative organisms have been replaced with ESBL positive
organisms.
Materials and Methods
Ethics statement
This study was conducted according to the principles expressed in
the Declaration of Helsinki. This study was approved by the scientific
and ethical committee of the HTD and Oxford tropical research
ethics committee (OXTREC) number 010-06 (2006). All parents of
the subject children were required to provide written informed
consent for the collection of samples and subsequent analysis.
Patient criteria
The work was conducted on the paediatric gastrointestinal
infections ward at the hospital for tropical diseases (HTD) in Ho
Chi Minh City in Vietnam. The HTD is a 500 bed tertiary referral
hospital treating patients from the surrounding provinces and from
the districts within Ho Chi Minh City. All patients from which Shigella
spp. were isolated were enrolled into a randomized controlled trial
comparing treatment with ciprofloxacin and gatifloxicin as described
previously [15] (trial number ISRCTN55945881). Briefly, all
children (aged 0–14 years) with dysentery (defined as passing bloody
diarrhoea or mucoid stools with additional abdominal pain or
tenesmus) whose parent or guardian gave fully informed written
consent were eligible for admission to the study. The primary
outcome of the trial was treatment failure, defined as the patient not
clearing symptoms after five days of antimicrobial treatment.
Microbiological culture and antimicrobial testing
Stool samples were collected from patients and cultured directly
on the day of sampling. Samples were cultured overnight in
selenite F broth (Oxoid, Basingstoke, UK) and plated onto
MacConkey and XLD agar (Oxoid) at 37uC. Colonies suggestive
of Shigella were sub-cultured on to nutrient agar and were
identified using a ‘short set’ of sugar fermentation reactions
(Kliger iron agar, urea agar, citrate agar, SIM motility-indole
media (Oxoid, United Kingdom)). Serologic identification was
performed by slide agglutination with polyvalent somatic (O)
antigen grouping sera, followed by testing with available
monovalent antisera for specific serotype identification as per the
manufacturer’s recommendations (Denka Seiken, Japan).
Antimicrobial susceptibility testing of all Shigella isolates against
ampicillin (AMP), chloramphenicol (CHL), trimethoprim – sulfa-
methoxazole (SXT), tetracycline (TET), nalidixic acid (NAL),
ofloxacin (OFX;) and ceftriaxone (CRO) was performed by disk
diffusion (Oxoid, United Kingdom). The minimum inhibitory
concentrations (MICs) were additionally calculated for all isolates
by E-test, according to manufacturer’s recommendations (AB
Biodisk, Sweden).
Those strains that were identified as resistant to ceftriaxone
using the disk diffusion susceptibility test were further subjected to
the combination disc method to confirm ESBL production
[23,24]. The combination disc method utilizes discs containing
only cefotaxime (CTX) (30 mg) and ceftazidime (CAZ) (30 mg) and
both antimicrobials combined with clavulanic acid (CLA) (10mg).
ESBL producing strains were identified as those with a greater
than 5 mm increase in zone with the single antimicrobial
compared to the combined antimicrobial, i.e. demonstrating
ESBL inhibition [25]. All antimicrobial testing was performed on
Mueller-Hinton agar, data was interpreted according to the
Clinical and Laboratory Standards Institute guidelines [26].
Genomic DNA isolation and DNA microarray
hybridisation
Genomic DNA was isolated from strains that were subjected to
PCR and DNA microarray hybridisation from 1 ml of a 5 ml
Author Summary
Shigellosis is a disease caused by bacteria belonging to
Shigella spp. and is a leading cause of bacterial gastroin-
testinal infections in infants in unindustrialized countries.
The Shigellae are dynamic and capable of rapid change
when placed under selective pressure in a human
population. Extended spectrum beta lactamases (ESBLs)
are enzymes capable of degrading cephalosporins (a
group of antimicrobial agents) and the genes that encode
them are common in pathogenic E. coli and other related
organisms in industrialized countries. In southern Vietnam,
we have isolated multiple cephalosporin-resistant Shigella
that express ESBLs. Furthermore, over two years these
strains have replaced strains isolated from patients with
shigellosis that cannot express ESBLs. Our work describes
the genes responsible for this characteristic and we
investigate one of the elements carrying one of these
genes. These finding have implications for treatment of
shigellosis and support the growing necessity for vaccine
development. Our findings also may be pertinent for other
countries undergoing a similar economic transition to
Vietnam’s and the corresponding effect on bacterial
populations.
blaCTX-M in Shigella spp.
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overnight bacterial culture using the wizard genomic DNA
extraction kit (Promega, USA), as per the manufacturer’s
recommendations.
For characterization of gene content of isolated Shigella strains,
genomic DNA was hybridized to an active surveillance of
pathogens (ASP) oligonucleotide microarray [27,28]. The ASP
array contains over 6,000 gene markers, including species
signature genes, virulence genes and antimicrobial resistance
genes from over a hundred bacterial species. Thus the ASP array
provides data for assessing horizontally transferred genes, such
data is helpful for diagnosis and for guiding antimicrobial therapy.
The ASP array used in this study was version 6.2 and was
designed and constructed as described previously [28]. Test
samples were labelled and hybridised as described previously [29].
Briefly, 5 mg genomic DNA was labelled with Cy5 and hybridised
with a formamide based hybridisation buffer solution in a final
volume of 48 ml at 50uC for 16–20 hours. The ASP arrays were
washed as described previously but with the initial wash at 50uC
[29]. The ASP arrays were scanned using a 418 microarray
Scanner (Affymetrix, USA) and intensity fluorescence data
acquired using ImaGene 7.5 (BioDiscovery, USA). Data was
analysed as described previously by Stabler et al. [28]. Briefly, a
reporter was considered positive if the background corrected mean
reporter signal from duplicate spots was both greater than one
standard deviation of reporter signal (reporter variation) and the
mean reporter signal was greater than the whole background
corrected microarray mean plus one standard deviation, as shown
for S. sonnei EG1007 in Dataset S1 in supporting information. The
raw microarray data for all isolates is presented in Dataset S2 in
supporting information.
Plasmid extraction and visualisation
Plasmid DNA was isolated from ESBL positive and ESBL
negative Shigella isolates using a modified version of the
methodology previously described by Kado and Liu [30]. The
resulting plasmid DNA was separated by electrophoresis in 0.7%
agarose gels made with 16 E buffer. Gels were run at 90 V for
3 h, stained with ethidium bromide and photographed. For DNA
sequencing plasmid DNA containing an ESBL gene was extracted
from an E. coli transconjugant using a NucleoBondH Xtra Midi kit
as per the manufacturers recommendations (Clontech, USA)
ESBL gene PCR amplification and characterisation
Genomic DNA was subjected to PCR amplification targeting
known classes of bla genes using, initially, primers that would
recognise sequences encoding SHV, (F; 59 TCTCCCTGTTAGC-
CACCCTG, R; 59; CCACTGCAGCAGCTGC) TEM (F; 59
TGCGGTATTATCCCGTGTTG, R; 59 TCGTCGTTTGG-
TATGGCTTC) and CTX-M (F; 59 CGATGTGCAGTACCAG-
TAA, R; 59 TTAGTGACCAGAATCAGCGG) class ESBLs
[31,32]. Further characterisation of the various sub-group of
blaCTX ESBL genes was performed using primers, CTX-M-1; (F 59
ATGGTTAAAAAATCACTGCG, R 59 TTACAAACCGT-
CGGTGAC), CTX-M-2; (F 59 TGGAAGCCCTGGAGAAA-
AGT and R 59 CTTATCGCTCTCGCTCTGT) and CTX-M-9;
(F 59ATGGTGACAAAGAGAGTGCAAC, R 59 TTACAG-
CCCTTCGGCGATG) using previously outlined PCR amplifica-
tion conditions [31,32].
To identify an association with CTX-M genes and the adjacent
ISEcp1 transposase, all ESBL positive strains were subjected
to PCR with primers forward primers Tnp24F 59 CAC-
TCGTCTGCGCATAAAGCGG, Tnp15F 59 CCGCCGTTT-
GCGCATA CAGCGG (for blaCTX-M-24 and blaCTX-M-15 respec-
tively) and reverse primer TnpR 59 AGATATGTAATCAT-
GAAGTTGTCGG. The Tnp24F and Tnp15F were located
within the blaCTX-M-24 and blaCTX-M-15 genes respectively and
TnpR was located within the ISEcp1 transposase gene. The bla-
transposase PCR was performed under the following conditions;
95uC for 1 minute, 30 cycles of 95uC for 30 seconds, 56uC for
30 seconds, 72uC for 1 minute 30 seconds and 72uC for
2 minutes. All PCRs were performed using Taq DNA polymerase
and appropriate recommended concentrations of reagents (Bio-
line, UK).
Positive PCR amplicons were cloned into cloning vector pCR
2.1 (Invitrogen, USA) and sequencing reactions were carried out
as recommended by the manufacturer using big dye terminators in
forward and reverse orientation on an ABI 3700 sequencing
machine (ABI, USA). All sequencing reactions were performed
twice to ensure correct sequencing and sequences were verified,
aligned and manipulated using Bioedit software (http://www.
mbio.ncsu.edu/BioEdit/bioedit.html). All ESBL gene sequences
were compared to other ESBL sequences by BLASTn at NCBI.
The DNA sequence of various classes of blaCTX were downloaded
and aligned with the produced sequences.
Bacterial conjugation
Bacterial conjugation experiments were performed by combin-
ing equal volumes (3 ml) of overnight Luria-Bertani cultures of
donor and recipient strains. The donor strains were Shigella clinical
isolates carrying blaCTX genes and the recipient was E. coli J53
(sodium azide resistant). Bacteria were conjugated for 12 hours at
37uC and transconjugants were selected on Luria-Bertani media
containing sodium azide (100 mg/ml) and ceftriaxone (6 mg/ml).
Potential transconjugants were verified by serotyping and plasmid
extraction.
Plasmid sequencing and annotation
Plasmid pEG356 was selected for DNA sequencing and
annotation as previously described [33]. The DNA sequence was
annotated to identify coding sequences and repeat sequences in
Artemis. To identify plasmids with similar sequences, pEG356 was
compared by BLASTn at NCBI. pAPEC-01-ColBM (Ac.
DQ381420) [34] was downloaded and aligned with pEG356
and viewed in Artemis Comparison Tool (ACT) [35]. Schematic
drawing of the sequence of pEG356 was constructed using
DNAplotter [36]. Artemis, ACT and DNAplotter are freely
available at (http://www.sanger.ac.uk/Software). The full se-
quence and annotation of pEG356 was submitted to EMBL with
the accession number FN594520.
Results
The escalating isolation rate of ESBL positive Shigella spp.
in Ho Chi Minh City
During a 24 month period between April 2007 and March 2009
we isolated 94 Shigella strains from the stools of children admitted
with dysentery. Of these 94 strains, 24 were S. flexneri and 70 were
S. sonnei, confirming the species substitution previously noted from
isolates in this region [15]. The general antibiotic sensitivity
patterns in these strains were variable, although resistance to
trimethoprim – sulfamethoxazole, tetracycline and latterly nali-
dixic acid were ubiquitous and there was an overall propensity of
sensitivity towards older generation antimicrobials such as
chloramphenicol (Table 1). A reversion of sensitivity to older
therapies highlights how antimicrobial resistance genes can be
maintained (or otherwise) by selective antimicrobial pressure in the
population.
blaCTX-M in Shigella spp.
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The first isolation of a ceftriaxone resistant organism during the
transitional period occurred in May 2007 and similar strains were
isolated in low numbers for the following months (Figure 1). The
numbers of Shigellae isolated that were resistant to ceftriaxone
fluctuated over the following 18 months. However, there was
increase in the proportion of resistant to sensitive isolates 19% to
41% (5 to 11) between the periods from April 2007–September
2007 and April 2008–September 2008, respectively. This trend
peaked in March 2009, with six out of seven Shigella strains isolated
resistant to ceftriaxone (MIC.256). The overall rate of resistance
to ceftriaxone between September 2008 and March 2009 was
75%.
The combined resistance patterns of ESBL producing
Shigella spp.
We initially cultured a ceftriaxone resistant S. sonnei strain in
2001 (DE 0611) (Table 1), however, this strain was a single,
isolated organism and a secondary ceftriaxone resistant Shigella was
not isolated again until 2007. Between 2007 and 2009, 35 (34%)
Shigella isolates cultured were resistant to ceftriaxone (Table 1). Of
these strains, 33 were S. sonnei and the other two isolates were S.
flexneri. In total, we isolated 36 ceftriaxone resistant organisms
between 2001 and 2009.
The mechanism of ceftriaxone resistance was examined by the
double disc inhibition method to identify ESBL producing
organisms. All the S. sonnei and one S. flexneri strain (35 from 36
ceftriaxone resistant Shigella) produced the characteristic ESBL
pattern on investigation, whereas the hydrolysing activity of the
other S. flexneri organism was not inhibited by clavulanic acid
[23,24] (Table 1).
The median age of patients harbouring third generation
cephalosporin resistant Shigellae was 32 months (range; 8 to 120
months), the median age of shigellosis patients during the same
period was 30 months [15]. Owing to the rapid increase in the rate
isolation of such organisms we hypothesised that an individual
dominant strain had began circulating in one area of Ho Chi
Minh City. However, residence data procured on the time of
admission showed that such strains were circulating over a wide
area of the city and not purely limited to an isolated outbreak
(Table 1). 12 patients were resident in surrounding provinces,
some 150 km from the hospital.
In conjunction with ceftriaxone, all strains were examined for
resistance to an additional five antimicrobials by disc diffusion and
MIC (Table 1). As predicted, all strains demonstrated co-resistance
to ampicillin. Thirty five of the 36 strains (97%) were resistant to
trimethoprim – sulfamethoxazole and tetracycline, whilst 33/36
were resistant to nalidixic acid. Only three isolates; DE0611,
EG0419 and EG0471 were co-resistant to chloramphenicol, of
which two, EG0419 and EG0471 (6%), were resistant to five of the
six antimicrobials tested (Table 1).
Identifying the genetic nature of ceftriaxone resistance in
Shigella spp.
The most common mechanism of dissemination of ESBL genes
in the Enterobacteriaceae is plasmid mediated transfer. Our previous
studies have suggested that Vietnam (and other parts of South East
Asia) may be hotspot for the origin and further transmission of
antimicrobial resistant organisms [8,13,37,38]. Enterobacteriaceae
which carry MDR plasmids are common in Vietnam and the
isolation of MDR Shigella strains has been repeatedly reported
[19,20,39].
We hypothesised that the ESBL phenotype was related to the
insertion of a transposon carried on an MDR plasmid that had
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permeated into and was circulating within the Shigella population.
To investigate the genetic nature of the ESBL positive isolates
compared to the ESBL negative isolates we hybridised genomic
DNA to an active surveillance of pathogens (ASP) DNA
microarray. In total, 15 isolates (seven ESBL positive and eight
ESBL negative) were compared. The ASP array is designed to
monitor gene flux, genetic content and the nature of horizontally
transferred DNA in a bacterial population. The resulting
hybridisation is shown in Figure 2. Concurrently, plasmid DNA
was isolated and compared from the same bacterial isolates to
assess plasmid content.
Figure 2 is a heatmap representation of the 142 ASP microarray
reporters which demonstrated positive hybridisation to DNA in
two or more of the S. sonnei samples and the 11 reporters
representing the S. sonnei Ss046 plasmid pSS_046. The overall
hybridisation data and the names and predicted functions of the
genes are presented in Dataset S2 (supporting information).
The pattern of relative hybridisation across all strains was
remarkably homogenous, with only 30% (42/142+11 pSS_046) of
the total proportion of the positive coding sequences demonstrat-
ing variable hybridisation patterns. The coding sequences
demonstrating common hybridisation patterns across all 15 strains
included a number of signature E. coli, Shigella spp. regions and
sequences corresponding to virulence and antimicrobial resistance
(Figure 2 and Supporting information Datasets S1 and S2).
The common antimicrobial resistance genes identified between
isolates included genes conferring resistance to streptomycin,
macrolides, tetracycline, beta lactams and also some unspecific
antimicrobial resistance efflux genes. The homogenous nature of
hybridisation suggests that variation between isolates is limited and
dependent on plasmid content. All the ESBL producing strains
demonstrated significant hybridisation to sequences corresponding
to bla genes, highlighted in Figure 2, DNA from the ESBL negative
strains failed to hybridise to these targets.
Plasmid visualisation of plasmid DNA by agarose gel electro-
phoresis with all hybridised strains revealed that in contrast to the
ESBL negative isolates, all the ESBL producing isolates had a
large plasmid, we roughly estimated to be greater than 63 Kbp in
size (according to the marker plasmid). Despite the ESBL negative
isolates lacking a large plasmid; these strains demonstrated similar
resistance profiles, with the obvious exception of ceftriaxone (data
not shown). These data suggested that the ESBL genes may be
located on simple (none MDR) extrachromosomal elements. This
hypothesis was supported by evidence of in vivo horizontal plasmid
transfer; two strains cultured two days apart from the same patient
were identical in serotype, plasmid content and MIC resistance
profile, with the exception of the secondary strain carrying a large
plasmid and displaying resistance to ceftriaxone (data not shown).
Furthermore, sequencing of a conjugative, ESBL encoding
plasmid confirmed our suggestion of a simple extrachromosomal
element.
Characterisation of bla genes
PCR was performed to detect the blaTEM, blaSHV and blaCTX-M
genes. Further PCR amplifications were performed on DNA from
all strains that produced amplicons with the blaCTX-M primers.
Figure 1. Graph depicting an increase in number and proportion of ceftriaxone resistant Shigella spp. isolated between April 2007 and
March 2009 at the hospital for tropical diseases in Ho Chi Minh City. The thick black line with circles represents the number of ceftriaxone
resistant Shigella isolates per month (x axis); the thin black line with triangles represents the total number of Shigella isolates per month (both related to
the left y axis). The broken line represents the proportion of strains isolated in six month periods resistant to ceftriaxone (right y axis). The increasing
proportion of ceftriaxone resistant organisms over six month periods is statistically significant (p=0.024) as calculated using the chi-squared test.
doi:10.1371/journal.pntd.0000702.g001
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Primers that were specific for the three major CTX-M clusters,
blaCTX-M-9, blaCTX-M-1 and blaCTX-M-2 were selected [40]. Three
strains (DE0611, EG0187 and EG0356) produced amplicons with
the blaCTX-M-9 primers and the remaining 32 isolates produced
amplicons with the blaCTX-M-1 primers (Table 2). All 35 PCR
amplicon were sequenced.
Sequence analysis of the PCR amplicons demonstrated that
there were two differing blaCTX-M genes present in the Shigella
population, these were, blaCTX-M-24 (n = 3, 8%) and blaCTX-M-15
(n = 32, 92%) (Table 2). Both genes (blaCTX-M-24 and blaCTX-M-15)
share 74% DNA homology with each other; blaCTX-M-15 and
blaCTX-M-24 differ by 12 and 6 nucleotides from the precursor
Figure 2. Demonstration of the absence and presence of genes from DNA isolated from ceftriaxone resistant and ceftriaxone
sensitive S. sonnei isolates using the ASParray. Red boxes indicate presence of genes; green boxes indicate absence of genes. BLAST indicates
reporter DNA identity (%) to the S. sonnei Ss046 genome. DNA was hybridized from isolates (left to right) DE0115, DE0477, DE0685, DE0891, DE1150,
DE1198, DE1256, DE0611, EG0204, EG0373, EG0395, EG0430, EG1007, EG1008 and EG1009.
doi:10.1371/journal.pntd.0000702.g002
Table 2. Characterisation of blaCTX-M genes and the corresponding plasmids of ESBL expressing Shigella spp.
Strain ID Ceftazidime zone (mm) blaCTX-M Plasmid size (kbp)
a Conjugation frequencyb bla -transposon PCR (+/2)
DE0611 28 CTX-M-24 70 4.43610 22 +
EG0162 18 CTX-M-15 100 2.73610 22 +
EG0187 27 CTX-M-24 70 2.58610 22 +
EG0204 19 CTX-M-15 100 1.93610 22 +
EG0250 19 CTX-M-15 100 4.43684 22 +
EG0250a 19 CTX-M-15 100 4.00684 22 +
EG0356 28 CTX-M-24 70 2.41610 22 +
EG0373 18 CTX-M-15 100 1.50610 22 +
EG0384 20 CTX-M-15 100 2.92610 22 +
EG0390 22 CTX-M-15 100 1.38610 22 +
EG0395 20 CTX-M-15 100 2.33610 22 +
EG0421 20 CTX-M-15 100 1.83610 24 +
EG0424 21 CTX-M-15 100 3.77610 23 +
EG0430 21 CTX-M-15 100 2.00610 24 +
EG0471 20 CTX-M-15 100 1.38610 22 +
EG0472 20 CTX-M-15 100 3.59610 23 +
EG1007 22 CTX-M-15 100 1.60610 22 +
EG1008 20 CTX-M-15 100 1.43610 22 +
EG1009 21 CTX-M-15 100 3.11610 25 +
EG1010 21 CTX-M-15 100 1.82610 22 +
EG1011 21 CTX-M-15 100 5.68610 26 +
EG1012 20 CTX-M-15 100 2.37610 22 +
EG1013 19 CTX-M-15 100 4.88610 26 +
EG1014 19 CTX-M-15 100 2.50610 23 +
EG1015 22 CTX-M-15 100 2.75610 23 +
EG1016 20 CTX-M-15 100 3.00610 24 +
EG1017 20 CTX-M-15 100 3.20610 22 +
EG1018 20 CTX-M-15 100 1.45610 22 +
EG1019 20 CTX-M-15 100 2.00610 22 +
EG1020 20 CTX-M-15 100 0 +
EG1021 21 CTX-M-15 100 1.85610 23 +
EG1022 21 CTX-M-15 100 3.75610 22 +
EG1023 21 CTX-M-15 100 8.57610 24 +
EG1024 20 CTX-M-15 100 3.43610 22 +
EG1025 20 CTX-M-15 100 2.36610 22 +
aEstimated plasmid size by agarose gel electrophoresis with known markers.
bConjugation frequency calculated per donor cell from the mean of two replicates.
doi:10.1371/journal.pntd.0000702.t002
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genes within their respective parent groups, (blaCTX-M-1 and
blaCTX-M-9).
Plasmid sizing, by visualisation of the previous agarose gel
electrophoresis demonstrated that the estimated plasmid size
corresponded with either the blaCTX-M gene (Table 2); blaCTX-M-15
was consistently located on a plasmid larger than that associated
with blaCTX-M-24. These observations were confirmed by Southern
blotting hybridisation of plasmid DNA extractions (data not
shown). The differing plasmid sizes and ESBL genes correlated
precisely with two distinct zone clearance areas when strains were
susceptibility tested with ceftazidime. The strains expressing CTX-
M-24 demonstrated less activity against ceftazidime when
compared to CTX-M-15 (median zone size, CTX-M-24; 28mm,
CTX-M-15; 20mm) (Table 2).
All blaCTX-M harbouring plasmids with the exception of the
plasmid in strain EG1020 were transmissible with high conjuga-
tion frequencies, ranging from 4.846102 to 4.886106 (median
1.556102) per donor cell (Table 2). The mobilisation of one of
these blaCTX harbouring plasmids was further demonstrated by
conjugative transfer of the plasmid originally from S. sonnei EG356
from an E.coli transconjugant back into a fully susceptible, naive S.
sonnei strain at a similarly high frequency.
DNA sequence analysis of the pEG356 plasmid
The ESBL encoding gene blaCTX-M-24 appears to be generally
restricted to Enterobacteriaceae in Asia [41,42], with only sporadic
reports of this gene in other locations [43]. Therefore, we selected
the plasmid from isolate EG0356, carrying a blaCTX-M-24, as it is
applicable to this location, for further characterisation by DNA
sequencing.
Plasmid pEG356 was found to be a circular replicon consisting
of 70,275 nucleotides, similar in size to another blaCTX-M-24
encoding plasmid from Asia; pKP96. pKP96 was isolated from a
Klebsiella pneumoniae strain from China in 2002, yet demonstrates
limited DNA homology to pEG356, with exception to the ESBL
encoding region [44]. pEG356 was comparatively GC neutral
(52.26%) and belonged to incompatibility group FI (on the basis of
the DNA sequence homology to the replication region) (Figure 3).
pEG356 was predicted to contain 104 coding sequences, of which
14 were considered to be pseudogenes on the basis of apparent
premature stop codons, frameshifts or missing start codons. The
density of coding sequencing approached 95% and contained four
main structural features, a replication region, the ESBL gene
encoding region with predicted homology to an ISEcp1 element,
an iron ABC transport system and a DNA transfer region (labelled
red, pink, dark blue and light blue, respectively in Figure 3).
pEG356 encoded the complete tra gene-set encoding a
conjugative pilus with high sequence similarity to the transfer
region from the F plasmid sequence from E. coli K12 [45] (Ac.
AP001918). This is consistent with the in vitro data demonstrating
that this plasmid is transmissible into an E. coli recipient. The IncFI
replication region was highly similar to other IncF plasmids,
including the recently described CTX-M-15 encoding plasmid
pEK499 (Ac. EU935739) isolated from an E. coli O25:H4-ST131
epidemic strain circulating in the United Kingdom [46].
Additionally, pEG356 shared another 30 Kbp (position 15,152
to 44,255 in pEG356) of high sequence similarity with pEK499
[46]. This region contains multiple common hypothetical plasmid
genes of unknown function, genes involved in conjugative transfer
(traM to traC), plasmid partitioning and a predicted single stranded
DNA binding protein (ssb). Unlike pEK499 the mok and hok post
segregational killing genes are missing from within the plasmid
maintenance region [46]. With respect to pEK499 and other
ESBL carrying plasmids, pEG356 does not carry multiple
antimicrobial resistance genes, transposons, insertion sequences
or any additional virulence associated genes [44,46,47](Chen et al.
2007; Shen et al. 2008; Woodford et al. 2009)(Chen et al. 2007;
Shen et al. 2008; Woodford et al. 2009).
In overall structure, but not size, pEG356 shared the most DNA
sequence similarity with the ColBM plasmid pAPEC-O1 (Ac.
DQ381420), isolated from an avian pathogenic E. coli strain [34]
(Figure 4). pEG356 shared around 80% of the gene content with
pAPEC-O1, including the conjugation (tra), replication (rep) and a
putative ATP iron transport system (iro). The iro region consisted of
four coding sequences, which include, a putative permease, an
iron binding protein and an export associated protein.
The blaCTX-M-24 was located on an ISEcp1 like element. The
overall sequence of the ISEcp1 variant on pEG356 is 4,725 bp and
3,000 bp shares 99% DNA homology with an ESBL gene
encoding element from an E. coli strain that was isolated in
China; pOZ174 (AF252622) [48]. The blaCTX-M-24 carrying
region is also highly similar (99% DNA homology) to the
equivalent region in the previously described plasmid, pKP96,
including the IS903D downstream of the blaCTX-M-24 gene
(Figure 4) [44].The ISEcp1 element contains two pairs of inverted
repeat (Figure 4): the larger inverted repeat (31 bp) flanks the
complete element, inclusive of six coding sequences. The 39end of
the ISEcp1 element contained a ISEcp1 transposase and a small
hypothetical coding sequence of unknown function which is
spanned by two IS1380 elements. The blaCTX-M-24 isadjacent to
two pseudogenes, which were understood to have encoded a
conserved hypothetical transposon protein and a maltose-induc-
ible porin precursor, it is not clear what significance, if any, these
genes are to the overall functionality of the element or the plasmid.
All ESBL producing Shigella were subjected to PCR to
demonstrate if all bla genes were associated with the ISEcp1
transposase. The location of the PCR primers Tnp24F and TnpR
are highlighted in Figure 4 and were designed to produce an
amplicon if the bla gene and the adjacent ISEcp1 transposase were
in the same location and orientation in strains with a blaCTX-M-24.
A secondary forward primer was designed in equivalent location
for those strains with a blaCTX-M-15 (Tnp15F). Therefore, if blaCTX-
M-24 or the blaCTX-M-15 was consistently adjacent to the ISEcp1
transposase it would produce an amplicon of 414 bp in all strains.
All ESBL positive strains (CTX-M-15 and CTX-M-24) generated
a PCR amplicon of the predicted size (Table 2). Sequencing of all
PCR products demonstrated that all the blaCTX-M-15 and the
blaCTX-M-24 gene were associated with an ISEcp1 transposase, The
DNA sequence from all PCR products was identical from within
the transposase gene up to and including the IS1380.
Discussion
Members of the Enterobacteriaceae that carry CTX-M family
ESBLs have been isolated from many parts of the world since the
mid 1990s [40]. CTX-M genes have been previously identified
from pathogenic Enterobacteriaceae circulating in South East Asia;
such as Vietnam, Thailand, Cambodia and Singapore [6,7,49,50].
Additionally, our work has shown that ESBLs are commonly
found in organisms which constitute the ‘‘normal’’ gastrointestinal
flora in the general population living in Ho Chi Minh City [8].
Such data predicts that intestinal flora may be a considerable
reservoir of ESBL encoding genes and the genetic elements they
circulate on, permitting potential transmission to their pathogenic
counterparts.
CTX-M genes in the Shigellae have been previously reported in
Argentina, (CTX-M-2) [51], Korea (CTX-M-14) [52] and from a
traveler returning from India (CTX-M-15) [53]. More recently,
blaCTX-M in Shigella spp.
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Nagano et al. described a novel CTX-M-64 hybrid from a
shigellosis patient infected with S. sonnei after returning to Japan
from China [54]. The S. sonnei strains isolated here in Ho Chi
Minh City harbored the blaCTX-M-15 and blaCTX-M-24 genes.
Current data suggests that blaCTX-M-24 is found mainly in Asia
[41,42], yet may have been transferred to other locations [43].
MDR CTX-M-15 producing E. coli is emerging worldwide as an
important pathogen causing hospital-acquired infections [2]. The
potential impact of MDR Shigella combined with CTX-M-15/24
carrying plasmids is substantial, with implications for local
treatment policy and the transportation of such plasmids into
other countries as has been implicated in Canada [43,55].
The structure of pEG356 as a vector for transferring blaCTX-M-
24 implies that such plasmids may be common. The streamlined
nature of pEG356, remarkably high conjugation frequency may
ensure onward circulation of the genetic cargo as it becomes stable
in the bacterial population. The simplistic nature of pEG356, with
a lack of additional resistance genes suggests that this is a
contemporary element, with the blaCTX-M-24 a recent acquisition.
The blaCTX-M-24 gene has been located on a relatively uncompli-
Figure 3. A schematic representation of the blaCTX-M-24 encoding plasmid, pEG356. pEG356 is a 70,275bp IncFI plasmid containing 104
coding sequences. The various features are highlighted by the various concentric circles according to the annotation of the of the plasmid (ac.
FN594520). The outer colored circle represents coding sequences on the forward strand, the second circle represents coding sequences on the
reverse strand. The coding sequences are coded by colour, red; plasmid replication, orange; conserved hypothetical, brown; pseudogene, dark blue;
adaptation, grey; segregation, light blue; conjugation/transfer, light pink; transposition, dark pink; degradation/resistance and yellow; metabolism.
The third concentric circle represents the location of pseudogenes and the fourth circle represents the four main modules of predicted function, red;
replication, pink; transposition, dark blue; iron transport and light blue; conjugational transfer. The fifth and final coloured circle represents the
location of the repeat sequences. The primary central graph (a) represents GC content, ranging from high (black) to low (grey) (mean 52%) and the
secondary central graph (b) represents G/C coding bias ranging from high (black) to low (grey). The ISEcp1 type element carrying the blaCTX-M-24 is
distinguished by grey shading.
doi:10.1371/journal.pntd.0000702.g003
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cated plasmid in Asia, however, pKP96 only demonstrates limited
homology to pEG356 [44].
All ESBL gene were located adjacent to a ISEcp1 transposase (as
identified by PCR). We are currently unable to substantiate if it is
the ISEcp1-like element, the plasmids or the circulation of bacterial
clone is responsible for the increasing rate of isolation. However,
the geographical spread of these strains suggests that they are
widely disseminated throughout southern Vietnam. S. sonnei is a
Figure 4. A schematic representation of ISEcp1-pEG356 and DNA sequence alignment highlighting corresponding DNA homology
between pEG356 and pAPEC-O1-ColBM. The DNA sequences for pEG356 and pAPEC-O1-ColBM were aligned and compared in Artemis comparison
tool (ACT). The numbers on the diagram correspond to the respective plasmid sizes and the black integers highlight 10 Kbp intervals. The genetic backbone
of the pEG356 and pAPEC-O1-ColBM is shown in yellow along with the various modules, red; rep (replication), pink; tn (transposition), dark blue; iro (iron
uptake) and light blue; tra (DNA transfer/conjugation). Areas with high DNA homology between pEG356 and pAPEC-O1-ColBM are shown with grey
shading and the pink shading corresponds to a magnified view of ISEcp1-pEG356. The numbers on ISEcp1-pEG356 correspond to the location of the
element on the host plasmid, with integers representing 1 Kb intervals. The genes are functionally coded, pink; tn (transposition), orange; unk (unknown
function), brown; psu (pseudogene) and dark pink; blaCTX-M-24, primer locations for the transposon PCR are highlight by Tnp24F and TnpR. The location of
the IS908D downstream of the blaCTX-M-24 is highlighted The region is flanked by an inverted repeat (blue triangles) and contains an additional inverted
repeat sequence flanking the transposase gene. Corresponding inverted repeats are linked by arrows.
doi:10.1371/journal.pntd.0000702.g004
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monophyletic bacterial pathogen, and owing to the lack of
sensitivity of existing sequence based methods such as multi locus
sequence typing [56], we are currently unable to confirm clonality
satisfactorily (data not shown). Further epidemiological investiga-
tion of CTX-M containing strains combined with a more sensitive
sequenced based methodology, such as is used for Salmonella Typhi
is required [57]. We are currently assessing the genetic nature of
the strain and the plasmids carrying the ESBL genes.
Our findings show a transfer from 0% to 75% ceftriaxone
resistance in S. sonnei over just two years in the key age group (1 to
3 years) for this disease. By sampling across the Ho Chi Minh City
area, covering approximately 150 sq kilometres of Vietnam and a
population of approximately 15 million people we have shown that
the genetic explanation for this resistance pattern is the
dissemination two distinct ESBL genes, of which one is dominant.
These are the leading source of ESBLs in clinical Shigella cases and
their rapid spread suggests that these organisms are under strong
selection pressure. The use of third generation cephalosporins,
such as oral cefpodoxime and cefixime in the community is
common in Vietnam, and places the even the short term usage of
ceftriaxone and other broad-spectrum cephalosporins in jeopardy.
Shigella spp. are capable of carrying multiple plasmids with an
array of phenotypes including virulence and antimicrobial
resistance [16,18]. The presence of Shigella in the gastrointestinal
tract of humans is an ideal environment to acquire horizontally
transferred genetic material. Small highly transmissible plasmids
that impinge on the fitness of the host may be rapidly disseminated
under appropriate conditions.
Vietnam is a country that in many respects is representative of
many parts of the world. The Vietnamese economy is developing
rapidly and the country is undergoing transition with an increasing
population, urbanisation and shifting patterns of infectious
diseases. In the past decade there has been a transition in species
from S. flexneri to S. sonnei in the Southern provinces of Vietnam.
With this shift has come the emergence of ESBL S. sonnei. These
findings from the Vietnamese population should perhaps serve as a
warning for other countries encountering the same economic
transition. The progressive evolution of pan-resistant Shigella makes
vaccine development an increasingly important objective.
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